首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Expert Review Of Vaccines

Expert Review Of Vaccines杂志,由Taylor and Francis Ltd.出版,于2002年创刊,Bimonthly,出版语言English,ISSN:1476-0584,E-ISSN:1744-8395。

投稿咨询
Expert Review Of Vaccines
Expert Review Of Vaccines
Expert Review Of Vaccines
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.6
CiteScore
9.9
期刊收录
SCI、SCIE

Expert Review Of Vaccines(中文译名:《疫苗专家评审》),ISSN:1476-0584,EISSN:1744-8395,是Taylor and Francis Ltd.出版的国际性学术期刊,创刊于2002年,以Bimonthly形式稳定发行,2026年总发文量约97篇。该刊采用非OA开放访问,学科归属为医学 - 免疫学。该刊是医学、免疫学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.6,2025年期刊CiteScore为9.9,2025年期刊自引率约3.6%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Expert Review Of Vaccines长期聚焦医学、免疫学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、免疫学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Italy、Belgium、France、Australia、CHINA MAINLAND等为核心发文国家与地区;GLAXOSMITHKLINECENTERS FOR DISEASE CONTROL & PREVENTION - USA、PFIZER、SOUTH AFRICAN MEDICAL RESEARCH COUNCIL、LAVAL UNIVERSITY、STELLENBOSCH UNIVERSITY、UNIVERSITY OF CAPE TOWN等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
IMMUNOLOGY 免疫学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
IMMUNOLOGY 免疫学
3区
否 是

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学
3区
否 是

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 42 / 183

77.3

学科:IMMUNOLOGY SCIE Q2 75 / 183

59.29

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q2 49 / 183

73.5

学科:IMMUNOLOGY SCIE Q2 70 / 183

62.02


中国学者近期发文

1
Epidemiological shifts in coxsackievirus A-induced hand, foot, and mouth disease in China, 2008-202

Author:Yu, Li; Zhao, Heng; Zhao, Xin; Wang, Jingjing; Liao, Yun; Li, Jun; Zheng, Huiwen; Li, Dandan; Li, Heng; Shi, Haijing; Liu, Longding

Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2652927

2
Evaluation of varicella outbreak control following implementation of a two-dose free vaccination policy in Wuxi, China (2014-2024

Author:Yang, Min; Wang, Lingling; Wang, Xuwen; Zhou, Lu; Yang, Xu; Jiang, Jingfeng; Yang, Kun; Chen, Qiujin; Xiu, Shixin; Lu, Yihan

Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2653758

3
An active surveillance study of adverse events following to Japanese encephalitis inactivated vaccine (JE-I) in Jiangsu Province, China, 2024-202

Author:Liu, Li; Zhang, Lei; Hu, Ran; Kang, Guodong; Yu, Jing; Sun, Xiang; Wang, Zhiguo

Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2653748

4
Vaccine hesitancy among 0-6-year-olds' guardians in Chongqing: a cross-sectional survey revealing how immunization program managers' robust comprehensive capacity for adverse events following immunization (AEFI) management mitigates hesitanc

Author:Xu, Binyue; Wang, Qing; Xu, Jiawei; Li, Jianqiao; Bai, Ningpei; Zhou, Chunbei

Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2640140

5
Influenza vaccination willingness and influencing factors among older adults in Chongqing China: a cross-sectional study based on the WHO's behavioral and social drivers of vaccination framewor

Author:Yang, Jule; Yang, Shuang; Xiong, Yu; Li, Baisong; Fu, Xiaoqing; Jia, Mengmeng; Qi, Li

Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2638826

6
Fc-mediated immune effector functions elicited by recombinant and live-attenuated herpes zoster vaccine

Author:Huang, Zhuangzhuang; Jin, Pengfei; Pan, Hongxing; Wei, Mingwei; Liang, Qi; Gan, Mingzhi; Li, Simin; Zhai, Xiangjun; Li, Jingxin

Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2626919

7
A self-controlled case series study on the safety of a live attenuated herpes zoster vaccine in Chin

Author:Cao, Xiang; Wei, Mingwei; Huo, Xiang; Liu, Yuanbao; Xu, Ming; Wang, Xiaoshan; Huang, Xianzhang; Ma, Hui; Xu, Na; Lu, Qiang; Ma, Shihua; Jin, Pengfei; Li, Jingxin

Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2626926

8
Adherence and efficacy of the 0-7-21-day versus the 0-1-6-month hepatitis B vaccination schedules among people who use drugs: a two-year randomized controlled tria

Author:Hou, Xianbin; Li, Ning; Zhang, Hailan; Liu, Wenjun; Zheng, Haichao; Zhuang, Tianyi; Zou, Zhuoru; Xia, Ruyi; Liu, Ying; Zhang, Hongyan; Hou, Tiejun; Chen, Zhijun; Chen, Baozhong; Wang, Fuzhen; Wang, Lirong; Wei, Xiaoli; Zhuang, Guihua

Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2626920

9
Research progress on immune mechanism and control strategy of dsRNA impurities in mRNA vaccin

Author:Liu, Xinjun; Hu, Chaoying; He, Qian; Bai, Yu; Zhang, Xuanxuan; Fu, Zhihao; Ma, Xiao; Xu, Miao; Liang, Zhenglun; Mao, Qunying

Journal: EXPERT REVIEW OF VACCINES. 2025; Vol. 24, Issue 1, pp. 457-469. DOI: 10.1080/14760584.2025.2510335

10
Cost-effectiveness of human papillomavirus vaccination among girls aged 9-16 years in China: a meta-analysi

Author:Fu, Xiaoya; Xia, Yilan; Zhou, Weiyu; Lu, Yihan

Journal: EXPERT REVIEW OF VACCINES. 2025; Vol. 24, Issue 1, pp. 524-534. DOI: 10.1080/14760584.2025.2517715


在线咨询

Expert Review Of Vaccines

国际简称:EXPERT REV VACCINES参考译名:疫苗专家评审

年发文量:97 CiteScore:9.9 是否预警:否 Gold OA文章占比:99.25% 研究类文章占比:73.20%

杂志社联系方式:EXPERT REVIEWS, UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB

Expert Review Of Vaccines